Preterm birth can be prevented with a few proven treatments, Lancet article say – Lowering preterm birth rates by an average of 5 percent across 39 high-resource countries, including the United States, by 2015 would prevent prematurity for 58,000 babies a year. In the Lancet, the expert group says prevention of preterm birth could save billions in economic costs.
Human papillomavirus (HPV) vaccine may benefit HIV infected women – Women with HIV may benefit from a vaccine for human papillomavirus (HPV), despite having already been exposed to HPV, a study finds. Although many may have been exposed to less serious forms of HPV, more than 45 percent of sexually active young women who have acquired HIV appear never to have been exposed to the most common high-risk forms of HPV.
NIH study finds women spend longer in labor now than 50 years ago — Changes in delivery practices appear to be main contributing factor – Women take longer to give birth today than did women 50 years ago, as per analysis of nearly 140,000 deliveries by NIH researchers in US. The change is likely due to changes in delivery room practice.
Cervical disease sufferers could benefit from HPV vaccine – HPV vaccination does not reduce progression to cervical disease in women, but vaccinated women had less frequent subsequent cervical disease. Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease.
The cervical cancer DNA test that could help cut cervical cancer deaths — HPV DNA Test ‘improves cancer screening’ – Implementation of HPV DNA testing in cervical screening leads to earlier detection of clinically relevant CIN grade 2 or worse, which when adequately treated, improves protection against CIN grade 3 or worse and cervical cancer. Early detection of high-grade cervical legions caused by HPV16 was a major component of this benefit.
New figures on cancer in Europe show a steady decline in mortality but big variations — Large variations in mortality exist between countries and between men and women – New figures on deaths from cancer in Europe show a steady decline in mortality between the periods 1990-1994 and 2000-2004. Deaths from all cancers in the European Union (EU) between these two periods fell by nine percent in men and eight percent in women, with a large drop among the middle-aged population.
First Cervical Cancer Screening Delayed Until Age 21 — Less Frequent Pap Tests Recommended. – Women should have their first cervical cancer screening at age 21 and can be rescreened less frequently than previously recommended, reported by US researchers at ACOG.
FDA-approved drugs fulvestrant and raloxifene eliminate, prevent cervical cancer in mice. – Researchers eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. The study is published in the Proceedings of the National Academy of Sciences.
Researchers find first evidence of virus in malignant prostate cells in prostate cancer — XMRV retrovirus is associated with more aggressive tumors of prostate gland. – XMRV (Xenotropic murine leukemia virus-related virus) — a type of virus known to cause leukemia and sarcomas in animals has been found for the first time in malignant human prostate cancer cells.
Complications early in pregnancy or in previous pregnancies adversely affect existing or subsequent pregnancies – Complications in early pregnancy or in previous pregnancies can predict the likelihood of further problems in current or subsequent pregnancies, revealed by researchers.
